Galectin Therapeutics Inc (GALT) Live Share Price, Invest From India

Galectin Therapeutics Inc Stock Performance

as on May 14, 2026 at 1:11 am IST

Day's Low
Day's High
$2.25
Day's Price Range
$2.30
$2.27
0.88%
Downside
1.32%
Upside
52 Week's Low
52 Week's High
$1.21
52-Week Price Range
$7.13
$2.27
46.70%
Downside
214.10%
Upside

Galectin Therapeutics Inc share price movements today

Previous Close: $2.25
Open: $2.25
Volume: 161.8K
Day's Low - High: $2.25 - $2.30
52 Week Low - High: $1.21 - $7.13

Galectin Therapeutics Inc Historical Returns

1 Month Return: -4.26 %
3 Month Return: -18.48 %
1 Year Return: + 70.45 %
3 Year Return: + 33.14 %
5 Year Return: 0 %

Galectin Therapeutics Inc Stock Fundamentals & Key Indicators

Check Galectin Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$145.5M

EPS (TTM)

-0.31

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-3727.95%

Galectin Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Galectin Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Galectin Therapeutics Inc	BUY	$145.5M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$38.0B	119.7%	71.39	12.55%
BeiGene, Ltd.	NA	$32.7B	NA	71.44	8.94%
Vertex Pharmaceuticals Inc	BUY	$110.4B	109.14%	25.84	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	39.88%	17.39	29.65%

Stock Returns calculator for Galectin Therapeutics Inc Stock including INR - Dollar returns

The Galectin Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Galectin Therapeutics Inc investment value today

Current value as on today

₹1,93,004

Returns

₹93,004

(+93%)

Returns from Galectin Therapeutics Inc Stock

₹71,970 (+71.97%)

Dollar Impact

₹21,035 (+21.03%)

Analyst Recommendation on Galectin Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Galectin Therapeutics Inc. Average target price of $11

Galectin Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Galectin Therapeutics Inc.

What analysts predicted

79.36%UPSIDE

Target Price

$11

Current Price

$2.27

Analyzed by

7 Analysts

Target

$11.00

Galectin Therapeutics Inc target price $11, a slight upside of 79.36% compared to current price of $2.27. According to 7 analysts rating.

Indian Investors' Interest in Galectin Therapeutics Inc Stock

Search interest for Galectin Therapeutics Inc Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:43% versus previous 30 day period

Galectin Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	0	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	-	0
Operating Income	-9	-9	-9	-11	-9	-12	-7	-4	-4	-3
EBITDA	-9	-9	-10	-11	-9	-10	-7	-5	-6	-3
Interest Expense	0	0	1	1	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	-	0
Income Before Tax	-10	-9	-11	-12	-11	-11	-9	-7	-8	-5
Income Tax Expense	0	-2	0	-	-	-	-	-	-	-
Net Income	-10	-9	-11	-12	-11	-11	-9	-7	-8	-5
Net Profit Margin	0.00%	-12496.25%	0.00%	0.00%	0.00%	-33241.67%	0.00%	0.00%	0.00%	0.00%

Galectin Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-21	-16	-13	-13	-23	-30	-38	-38	-42	-20
EBITDA	-21	-16	-13	-13	-23	-29	-37	-38	-41	-23
Interest Expense	-	0	0	0	0	0	1	2	5	7
Depreciation	-	0	-	0	0	0	0	0	0	0
Income Before Tax	-21	-16	-13	-13	-23	-30	-38	-41	-47	-30
Income Tax Expense	-	0	-	0	0	0	0	-2	-	-
Net Income	-21	-16	-13	-13	-23	-30	-38	-41	-47	-30
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Galectin Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-9	-11	-12	-11	-11	-9	-7	-8	-5
Operating Cash Flow	-4	-12	-8	-8	-12	-7	-6	-3	-6
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	10	10	10	10	0	-	12	1	12
Change in Cash	5	-2	2	1	-11	-7	6	-2	6

Galectin Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-13	-13	-23	-30	-38	-41	-47	-30
Operating Cash Flow	-15	-10	-10	-20	-24	-31	-32	-41	-23
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	3	15	50	0	36	10	40	31	26
Change in Cash	-12	5	39	-20	12	-21	7	-10	2

Global Institutional Holdings in Galectin Therapeutics Inc

Funds	Holdings
Jane Street Group LLC	0.3%
Geode Capital Management, LLC	0.91%
Geneos Wealth Management Inc	0.37%
Millennium Management LLC	0.36%
Sovran Advisors, LLC	0.34%

See all

Insights on Galectin Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, GALT has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, GALT has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Price Dip
In the last 6 months, GALT stock has moved down by -59.3%

About Galectin Therapeutics Inc

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension. It has a joint venture co-owned by SBH Sciences, Inc. to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Organisation	Galectin Therapeutics Inc
Headquarters	4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071
Industry	Biotechnology
CEO	Mr. Joel Lewis CPA
E-voting on shares	Click here to vote

Key Management of Galectin Therapeutics Inc

Name	Title
Mr. Jim Wilkins Ph.D.	Head of CMC & Pharmaceutical Development
Ms. Beth Knowles	Executive Assistant & Officer Manager
Mr. Joel Lewis CPA	President & CEO
Mr. Jack W. Callicutt CPA	CFO, Treasurer & Corporate Secretary
Dr. Khurram Jamil M.D.	Chief Medical Officer
Mr. Robert Tritt J.D.	General Counsel

FAQs

What is Galectin Therapeutics Inc share price today?

Galectin Therapeutics Inc share price today is $2.27 as on May 13, 2026 at 7:41 pm IST. Galectin Therapeutics Inc share today touched a day high of $2.3 and a low of $2.25.

What is the 52 week high and 52 week low for Galectin Therapeutics Inc share?

Galectin Therapeutics Inc share touched a 52 week high of $7.13 on December 17, 2025 and a 52 week low of $1.21 on May 16, 2025. Galectin Therapeutics Inc stock price today i.e. May 13, 2026 at 7:41 pm IST is trending at $2.27,which is 68.16% down from its 52 week high and 87.60% up from its 52 week low.

What is Galectin Therapeutics Inc's market capitalisation today?

Galectin Therapeutics Inc market capitalisation is $0.00T as on May 13, 2026 at 7:41 pm IST.

How to invest in Galectin Therapeutics Inc Stock (GALT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Galectin Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Galectin Therapeutics Inc Shares that will get you 0.6608 shares as per Galectin Therapeutics Inc share price of $2.27 per share as on May 13, 2026 at 7:41 pm IST.

What is the minimum amount required to buy Galectin Therapeutics Inc Stock (GALT) from India?

Indian investors can start investing in Galectin Therapeutics Inc (GALT) shares with as little as ₹95.705 or $1 (as of May 13, 2026 at 7:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Galectin Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 7:41 pm IST). Based on Galectin Therapeutics Inc share’s latest price of $2.27 as on May 13, 2026 at 7:41 pm IST, you will get 4.4053 shares of Galectin Therapeutics Inc. Learn more about fractional shares .